Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01010568 · ClinicalTrials.gov registry record · Phase 2
Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL)
A Phase 2 study, sponsored by Georgetown University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT01010568: Clinical Trial Phase 2 study, sponsored by Georgetown University.
NCT01010568 is a Phase 2 study that was terminated before completion, run by Georgetown University. The registered enrollment target is 10 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01010568, a Phase 2 study, was terminated before completion, sponsored by Georgetown University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the combination of bendamustine and ofatumumab in subjects with relapsed/refractory chronic lymphocytic leukemia and small cell lymphoma. All subjects enrolled on this study will receive both drugs by intravenous (IV) infusion.
Primary Outcome
40% per the National Cancer Institute Working Group Response Criteria for Chronic Lymphocytic Leukemia
Interventions
- DRUG Ofatumumab and Bendamustine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2010-04 |
| Est. Completion | 2014-08 |
| Phase | Phase 2 |
Why NCT01010568 stopped before completion
NCT01010568 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Ofatumumab and Bendamustine is the first listed.
NCT01010568 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01010568 about?
NCT01010568 is a clinical study titled "Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL)". The purpose of this study is to evaluate the safety and effectiveness of the combination of bendamustine and ofatumumab in subjects with relapsed/refractory chronic lymphocytic leukemia and small cell lymphoma. All subjects enrolled on this study will receive both drugs by intravenous (IV) infusion.
What is the current status of trial NCT01010568?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2010-04. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01010568?
The interventions under investigation include: Ofatumumab and Bendamustine (DRUG).
Who is sponsoring clinical trial NCT01010568?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01010568's enrollment target sits among peer trials
10 1968th of 2000 higher than 12 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia